Plaque psoriasis is one of the most commonly found types of psoriasis and creates a lot of trouble for the patients suffering from the disease. It builds up scaly, red, itchy patches on various parts of the body and can very easily become unmanageable. Cosentyx produced by Novartis pharmaceutical consists of the antibody of secukinumab which is known to reduce these effects by inhibiting a pro-inflammatory cytokine called interleukin-17A.
Just like in the case of any other medicine, cosentyx has to be taken in the exact way it was prescribed.
It has the capability of lowering the power of your immune system, hence it is extremely important to let your doctor know of any medication you would currently be on and any disease or problem you might be going through at the time this medicine is being prescribed to you. In particular, do not forget to mention to your doctor if you have ever had tuberculosis, if it runs in your family, if anyone in your household is currently affected with it or if you have or plan to visit an area where tuberculosis is common. Along with this data, in order to make sure that Cosentyx is safe for you, mention any hint of Crohn’s disease that you might have to your doctor at the time of prescription. Cosentyx hasn’t shown to cause any problems in pregnant women and unborn babies. However, it is not known if it has the capability to pass into breast milk. So, do make it a point to mention it to your doctor if you are or are planning on becoming pregnant or are breastfeeding.
Cosentyx comes as a clear to light yellow colored liquid. You are advised to not administer it if it has a cloudy appearance or any presence of particles in it. Once prescribed, it is to be taken once a week for 4 weeks and then a dosage of once every 4 weeks will be practiced. The most common side effects include a sore throat, diarrhea, hives, athlete’s foot, tonsillitis, oral thrush, upper respiratory tract infection, impetigo etc.
Disclaimer:The content provided on our blog site traverses numerous categories, offering readers valuable and practical information. Readers can use the editorial team’s research and data to gain more insights into their topics of interest. However, they are requested not to treat the articles as conclusive. The website team cannot be held responsible for differences in data or inaccuracies found across other platforms. Please also note that the site might also miss out on various schemes and offers available that the readers may find more beneficial than the ones we cover.
